UNSPSC 85893661: High dose rate (hdr) brachytherapy of ureter using palladium 103 (pd-103)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of ureter using palladium 103 (pd-103). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DT119BZ

UNSPSC 85893661 High dose rate (hdr) brachytherapy of ureter using palladium 103 (pd-103), a Commodity code, shows no relevant recent state and local procurement activity. The single recent opportunity posted under this code — County of Santa Clara Health System solicitation RFSQHHSFY270052 for temporary health professional staffing services across multiple ancillary clinical categories — bears no relationship to the code's stated scope of palladium-103 brachytherapy treatment for ureteral malignancy. The Santa Clara Health System RFQ, posted July 7, 2026, with a response date of October 7, 2026, seeks vendors to staff roles in audiology, cardiology, diagnostic imaging, gastroenterology, and related clinical support functions, not radiation oncology or brachytherapy services. This appears to reflect a state or local procurement taxonomy mismatch rather than active market demand for the specialized urological brachytherapy treatment the code nominally describes.

No additional state or local opportunities under this code are available to characterize geographic spread, issuing-body mix, or representative procurement patterns. The code warrants monitoring, but available data does not support a pursue strategy at this time.